Date:11/19/2009

,350) (10,306) Retained earnings(1) 1,094,613 1,028,540 884,671 129,599 Total shareholders' equity 1,844,583 1,926,270 1,802,530 264,060 Total liabilities and shareholders' equity 5,783,176 5,780,396 5,452,443 798,752 Note: (1) As a result of the adoption of new authoritative guidance changing the accounting for convertible instruments that can be settled in cash or partially in cash upon conversion, the Company adjusted relevant numbers in the condensed consolidated balance sheet as of March 31, 2009 retrospectively in accordance with GAAP. China Medical Technologies, Inc. Unaudited Condensed Consolidated Statements of Income For the Three Months Ended September 30, 2008 June 30, 2009 September 30, 2009 RMB RMB RMB US$ As As previously adjusted reported (3) (in thousands except for per ADS information) Revenues(1) 193,967 193,967 208,957 166,066 24,328 Cost of revenues (57,308) (57,308) (55,413) (57,517) (8,426) Gross profit 136,659 136,659 153,544 108,549 15,902 Operating expenses: Research and development (6,338) (6,338) (11,703) (9,500) (1,392) Sales and marketing (11,250) (11,250) (10,870) (17,432) (2,554) General and Administrative (25,472) (25,472) (46,954) (45,130) (6,611) Amortization of SPR intangible assets -- -- (27,352) (27,357) (4,008) Total operating expenses (43,060) (43,060) (96,879) (99,419) (14,565) Operating income 93,599 93,599 56,665 9,130 1,
'/>"/>

SOURCE China Medical Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine news :

1. China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009
2. Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
3. Novartis to Acquire Majority Stake in Hard to Treat Diseases (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million
4. Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
5. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
6. China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores
7. China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 2009
8. China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
9. Perot Systems Announces Strategic Alliance With China Telecom
10. China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan
11. Niusule Launches Niusule Gummy Bears in China